{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:18Z","timestamp":1787671698044,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK127984"],"award-info":[{"award-number":["P30 DK127984"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR180056"],"award-info":[{"award-number":["RR180056"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00843-0","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:05:28Z","timestamp":1784700328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-brain barrier water permeability is elevated in type 2 diabetes and obesity: associations with cognitive function and metabolic markers"],"prefix":"10.1186","volume":"23","author":[{"given":"Anujit","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad N.","family":"Elsharydah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Schaffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennine","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime P.","family":"Almandoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-3251","authenticated-orcid":false,"given":"Binu P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"843_CR1","doi-asserted-by":"publisher","unstructured":"Parker ED, et al. Economic costs of diabetes in the U.S. in 2022, (in eng). Diabetes Care. 2024;47(1):26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085.","DOI":"10.2337\/dci23-0085"},{"issue":"10","key":"843_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Reviews Endocrinol. 2018;14(10):591\u2013604.","journal-title":"Nat Reviews Endocrinol"},{"key":"843_CR3","doi-asserted-by":"publisher","unstructured":"Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission, (in eng). Lancet. 2020;396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/s0140-6736(20)30367-6.","DOI":"10.1016\/s0140-6736(20)30367-6"},{"key":"843_CR4","doi-asserted-by":"publisher","unstructured":"13. Older adults: standards of care in diabetes-2026, (in eng). Diabetes Care. 2026;49(Supplement_1):S277\u2013s296. https:\/\/doi.org\/10.2337\/dc26-S013.","DOI":"10.2337\/dc26-S013"},{"key":"843_CR5","doi-asserted-by":"publisher","unstructured":"Biessels GJ, Nobili F, Teunissen CE, Sim\u00f3 R, Scheltens P. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective, (in eng). Lancet Neurol. 2020;19(8):699\u2013710. https:\/\/doi.org\/10.1016\/s1474-4422(20)30139-3.","DOI":"10.1016\/s1474-4422(20)30139-3"},{"issue":"12","key":"843_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jamaneurol.2022.3472","volume":"79","author":"S Oveisgharan","year":"2022","unstructured":"Oveisgharan S, et al. Frequency and underlying pathology of pure vascular cognitive impairment. JAMA Neurol. 2022;79(12):1277\u201386.","journal-title":"JAMA Neurol"},{"issue":"1","key":"843_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jacc.2025.11.008","volume":"87","author":"PS Sachdev","year":"2026","unstructured":"Sachdev PS, et al. Vascular cognitive impairment and dementia: clinical features, neuropathology, and biomarkers. J Am Coll Cardiol. 2026;87(1):52\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"843_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1590\/1980-57642016dn11-040006","volume":"11","author":"FK Sudo","year":"2017","unstructured":"Sudo FK, Amado P, Alves GS, Laks J, Engelhardt E. A continuum of executive function deficits in early subcortical vascular cognitive impairment: A systematic review and meta-analysis. Dement neuropsychologia. 2017;11(4):371\u201380.","journal-title":"Dement neuropsychologia"},{"key":"843_CR9","doi-asserted-by":"publisher","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659\u201373. https:\/\/doi.org\/10.1038\/s41380-022-01511-z.","DOI":"10.1038\/s41380-022-01511-z"},{"key":"843_CR10","doi-asserted-by":"publisher","unstructured":"Rom S, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models, (in eng). Mol Neurobiol. 2019;56(3):1883\u20131896. https:\/\/doi.org\/10.1007\/s12035-018-1195-5.","DOI":"10.1007\/s12035-018-1195-5"},{"key":"843_CR11","doi-asserted-by":"publisher","unstructured":"Feng Z, Fang C, Ma Y, Chang J. Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms, (in eng). J Neuroinflammation. 2024;21(1):110. https:\/\/doi.org\/10.1186\/s12974-024-03104-9.","DOI":"10.1186\/s12974-024-03104-9"},{"issue":"5","key":"843_CR12","doi-asserted-by":"publisher","first-page":"e0177447","DOI":"10.1371\/journal.pone.0177447","volume":"12","author":"T Machida","year":"2017","unstructured":"Machida T, et al. Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model. PLoS ONE. 2017;12(5):e0177447. https:\/\/doi.org\/10.1371\/journal.pone.0177447.","journal-title":"PLoS ONE"},{"key":"843_CR13","doi-asserted-by":"publisher","unstructured":"van de Haar HJ, et al. Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology. 2017;282(2):615. https:\/\/doi.org\/10.1148\/radiol.2017164043.","DOI":"10.1148\/radiol.2017164043"},{"key":"843_CR14","doi-asserted-by":"publisher","unstructured":"Zhu P, Xiao L, Wang Y. Mechanisms of high-density lipoprotein in regulating blood-brain barrier function: insights and implications, (in eng). Fluids Barriers CNS. 2025;22(1):113. https:\/\/doi.org\/10.1186\/s12987-025-00721-1.","DOI":"10.1186\/s12987-025-00721-1"},{"key":"843_CR15","doi-asserted-by":"publisher","unstructured":"Rom S, Heldt NA, Gajghate S, Seliga A, Reichenbach NL, Persidsky Y. Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles, (in eng). Sci Rep. 2020;10(1):7274. https:\/\/doi.org\/10.1038\/s41598-020-64349-x.","DOI":"10.1038\/s41598-020-64349-x"},{"key":"843_CR16","doi-asserted-by":"publisher","unstructured":"Prasad S, Sajja RK, Naik P, Cucullo L. Diabetes mellitus and blood-brain barrier dysfunction: an overview, (in eng). J Pharmacovigil. 2014;2(2):125. https:\/\/doi.org\/10.4172\/2329-6887.1000125.","DOI":"10.4172\/2329-6887.1000125"},{"key":"843_CR17","doi-asserted-by":"publisher","unstructured":"Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging, (in eng). J Neurol Neurosurg Psychiatry. 2003;74(1):70\u20136. https:\/\/doi.org\/10.1136\/jnnp.74.1.70.","DOI":"10.1136\/jnnp.74.1.70"},{"key":"843_CR18","doi-asserted-by":"publisher","unstructured":"Qiao L, et al. Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment. Aging Clin Exp Res. 2026. https:\/\/doi.org\/10.1007\/s40520-025-03316-w.","DOI":"10.1007\/s40520-025-03316-w"},{"key":"843_CR19","doi-asserted-by":"publisher","unstructured":"Lin Z, et al. Non-contrast MR imaging of blood-brain barrier permeability to water, (in eng). Magn Reson Med. 2018;80(4):1507\u20131520. https:\/\/doi.org\/10.1002\/mrm.27141.","DOI":"10.1002\/mrm.27141"},{"issue":"4","key":"843_CR20","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/mrm.70168","volume":"95","author":"W Shi","year":"2026","unstructured":"Shi W, et al. Non-contrast assessment of blood\u2013brain barrier permeability to water: improved signal modeling and data acquisition. Magn Reson Med. 2026;95(4):1998\u20132008. https:\/\/doi.org\/10.1002\/mrm.70168.","journal-title":"Magn Reson Med"},{"key":"843_CR21","doi-asserted-by":"publisher","unstructured":"Stringer MS, et al. Gadolinium- and water-based blood-brain barrier dysfunction measures in patients with sporadic small vessel disease. Cereb Circulation - Cognition Behav. 2026;10:100528. https:\/\/doi.org\/10.1016\/j.cccb.2026.100528.","DOI":"10.1016\/j.cccb.2026.100528"},{"key":"843_CR22","doi-asserted-by":"publisher","unstructured":"Lin Y, et al. Noncontrast assessment of blood\u2013brain barrier permeability to water: Shorter acquisition, test\u2013retest reproducibility, and comparison with contrast-based method. Magn Reson Med. 2021;86(1):143-56. https:\/\/doi.org\/10.1002\/mrm.28687","DOI":"10.1002\/mrm.28687"},{"key":"843_CR23","doi-asserted-by":"publisher","unstructured":"Lin Z, et al. Blood-brain barrier breakdown in relationship to Alzheimer and Vascular disease, (in eng). Ann Neurol. 2021;90(2):227\u2013238. https:\/\/doi.org\/10.1002\/ana.26134.","DOI":"10.1002\/ana.26134"},{"key":"843_CR24","doi-asserted-by":"publisher","unstructured":"Peng SL, et al. Optimization of phase-contrast MRI for the quantification of whole-brain cerebral blood flow, (in eng). J Magn Reson Imaging. 2015;42(4):1126\u201333. https:\/\/doi.org\/10.1002\/jmri.24866.","DOI":"10.1002\/jmri.24866"},{"key":"843_CR25","doi-asserted-by":"publisher","unstructured":"Shi W, et al. VICTR: Venous transit time imaging by changes in T(1) relaxation, (in eng). Magn Reson Med. 2024;92(1):158\u201372. https:\/\/doi.org\/10.1002\/mrm.30051.","DOI":"10.1002\/mrm.30051"},{"key":"843_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1748-1716.1963.tb02652.x","volume":"58","author":"C Crone","year":"1963","unstructured":"Crone C. The permeability of capillaries in various organs as determined by use of the \u2018indicator diffusion\u2019 method. Acta Physiol Scand. 1963;58:292\u2013305.","journal-title":"Acta Physiol Scand"},{"key":"843_CR27","doi-asserted-by":"publisher","unstructured":"Li W, Grgac K, Huang A, Yadav N, Qin Q, van Zijl PC. Quantitative theory for the longitudinal relaxation time of blood water, (in eng). Magn Reson Med. 2016;76(1):270\u201381. https:\/\/doi.org\/10.1002\/mrm.25875.","DOI":"10.1002\/mrm.25875"},{"key":"843_CR28","doi-asserted-by":"publisher","unstructured":"Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E, and I. The Alzheimer\u2019s disease neuroimaging, CAT: a computational anatomy toolbox for the analysis of structural MRI data, (in eng). Gigascience. 2024;13. https:\/\/doi.org\/10.1093\/gigascience\/giae049.","DOI":"10.1093\/gigascience\/giae049"},{"key":"843_CR29","doi-asserted-by":"publisher","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883.","DOI":"10.1007\/BF00280883"},{"key":"843_CR30","doi-asserted-by":"publisher","first-page":"1239335","DOI":"10.3389\/fendo.2023.1239335","volume":"14","author":"M Laakso","year":"2023","unstructured":"Laakso M, Fernandes Silva L. Statins and risk of type 2 diabetes: mechanism and clinical implications, (in eng). Front Endocrinol (Lausanne). 2023;14:1239335. https:\/\/doi.org\/10.3389\/fendo.2023.1239335.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"843_CR31","doi-asserted-by":"publisher","unstructured":"Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia, (in eng). Diabetes Metab J. 2015;39(5):353\u201362. https:\/\/doi.org\/10.4093\/dmj.2015.39.5.353.","DOI":"10.4093\/dmj.2015.39.5.353"},{"key":"843_CR32","doi-asserted-by":"publisher","unstructured":"Shao X, Ma SJ, Casey M, D\u2019Orazio L, Ringman JM, Wang DJJ. Mapping water exchange across the blood-brain barrier using 3D diffusion-prepared arterial spin labeled perfusion MRI. Magn Reson Med. 2019;81(5):3065\u201379. https:\/\/doi.org\/10.1002\/mrm.27632.","DOI":"10.1002\/mrm.27632"},{"key":"843_CR33","doi-asserted-by":"publisher","unstructured":"Long C, Pu Y, Keng S, Tao J, Zhang B, Yue R. Novel insights into the mechanism and treatment of diabetes-related brain complications: focusing on the blood-brain barrier impairment. Aging Dis. 2026;17(4):1809-1833. https:\/\/doi.org\/10.14336\/ad.2025.0296.","DOI":"10.14336\/ad.2025.0296"},{"key":"843_CR34","doi-asserted-by":"publisher","unstructured":"Konishi M, et al. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Nat Acad Sci. 2017;114(40):E8478\u2013E8487. https:\/\/doi.org\/10.1073\/pnas.1710625114.","DOI":"10.1073\/pnas.1710625114"},{"key":"843_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2019.00521","volume":"13","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA. Role of the blood-brain barrier in central nervous system insulin resistance, (in eng). Front Neurosci. 2019;13:521. https:\/\/doi.org\/10.3389\/fnins.2019.00521.","journal-title":"Front Neurosci"},{"key":"843_CR36","doi-asserted-by":"publisher","unstructured":"Wang Z, Tang X, Swaminathan SK, Kandimalla KK, Kalari KR. Mapping the dynamics of insulin-responsive pathways in the blood-brain barrier endothelium using time-series transcriptomics data, (in eng). NPJ Syst Biol Appl. 2022;8(1):29. https:\/\/doi.org\/10.1038\/s41540-022-00235-8.","DOI":"10.1038\/s41540-022-00235-8"},{"key":"843_CR37","doi-asserted-by":"publisher","unstructured":"Raza A, et al. From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer\u2019s disease, (in eng). Metab Brain Dis. 2025;40(7):276. https:\/\/doi.org\/10.1007\/s11011-025-01700-z.","DOI":"10.1007\/s11011-025-01700-z"},{"key":"843_CR38","doi-asserted-by":"publisher","unstructured":"Abdalla MMI. Insulin resistance as the molecular link between diabetes and Alzheimer\u2019s disease, (in eng). World J Diabetes. 2024;15(7):1430\u201347. https:\/\/doi.org\/10.4239\/wjd.v15.i7.1430.","DOI":"10.4239\/wjd.v15.i7.1430"},{"key":"843_CR39","doi-asserted-by":"publisher","unstructured":"Yuhanna IS, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase, (in eng). Nat Med. 2001;7(7):853\u20137. https:\/\/doi.org\/10.1038\/89986.","DOI":"10.1038\/89986"},{"key":"843_CR40","doi-asserted-by":"publisher","unstructured":"Cheng AM, et al. Apolipoprotein A-I attenuates palmitate-mediated NF-\u03baB activation by reducing Toll-like receptor-4 recruitment into lipid rafts, (in eng). PLoS One. 2012;7(3):e33917. https:\/\/doi.org\/10.1371\/journal.pone.0033917.","DOI":"10.1371\/journal.pone.0033917"},{"key":"843_CR41","doi-asserted-by":"publisher","unstructured":"Yan Z, Xu Y, Li K, Liu L. Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis, (in English), Front Endocrinol. 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1272314.","DOI":"10.3389\/fendo.2024.1272314"},{"key":"843_CR42","doi-asserted-by":"publisher","unstructured":"Klimentidis YC, et al. Phenotypic and genetic characterization of lower LDL cholesterol and increased type 2 diabetes risk in the UK biobank, (in eng). Diabetes. 2020;69(10):2194\u20132205. https:\/\/doi.org\/10.2337\/db19-1134.","DOI":"10.2337\/db19-1134"},{"key":"843_CR43","doi-asserted-by":"publisher","unstructured":"Feng Q, et al. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: a US-based cross-sectional observational study using electronic health records, (in eng). PLoS Med. 2018;15(8):e1002642. https:\/\/doi.org\/10.1371\/journal.pmed.1002642.","DOI":"10.1371\/journal.pmed.1002642"},{"issue":"2","key":"843_CR44","doi-asserted-by":"publisher","first-page":"e14283","DOI":"10.1111\/apha.14283","volume":"241","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Verkhratsky A, Chen H, Yi C. Understanding glucose metabolism and insulin action at the blood\u2013brain barrier: Implications for brain health and neurodegenerative diseases. Acta Physiol. 2025;241(2):e14283. https:\/\/doi.org\/10.1111\/apha.14283.","journal-title":"Acta Physiol"},{"key":"843_CR45","doi-asserted-by":"publisher","unstructured":"Li X, Cai Y, Zhang Z, Zhou J. Glial and vascular cell regulation of the blood-brain barrier in diabetes, (in eng). Diabetes Metab J. 2022;46(2):222\u2013238. https:\/\/doi.org\/10.4093\/dmj.2021.0146.","DOI":"10.4093\/dmj.2021.0146"},{"key":"843_CR46","doi-asserted-by":"publisher","unstructured":"Siddiquee AT, et al. Middle-age cerebral small vessel disease and cognitive function in later life: a population-based prospective cohort study. Lancet Reg Health \u2013 Western Pac. 2025;55. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101284.","DOI":"10.1016\/j.lanwpc.2024.101284"},{"key":"843_CR47","doi-asserted-by":"publisher","unstructured":"Anwar N, et al. Cognition and brain oxygen metabolism improves after bariatric surgery-induced weight loss: a pilot study, (in English), Front Endocrinol. 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.954127.","DOI":"10.3389\/fendo.2022.954127"},{"key":"843_CR48","doi-asserted-by":"publisher","unstructured":"Tucker WJ, et al. Impact of bariatric surgery on cerebral vascular reactivity and cognitive function: a non-randomized pilot study. Pilot Feasibility Stud. 2020;6(1):21. https:\/\/doi.org\/10.1186\/s40814-020-00569-2.","DOI":"10.1186\/s40814-020-00569-2"},{"key":"843_CR49","doi-asserted-by":"publisher","unstructured":"Mohammed SR, Elmasry K, El-Gamal R, El-Shahat MA, Sherif RN. Alteration of aquaporins 1 and 4 immunohistochemical and gene expression in the cerebellum of diabetic albino rat, (in eng). Tissue Cell. 2023;82:102076. https:\/\/doi.org\/10.1016\/j.tice.2023.102076.","DOI":"10.1016\/j.tice.2023.102076"},{"issue":"9","key":"843_CR50","doi-asserted-by":"publisher","first-page":"e107022","DOI":"10.1371\/journal.pone.0107022","volume":"9","author":"J Deng","year":"2014","unstructured":"Deng J, et al. Expression of aquaporin 4 and breakdown of the blood-brain barrier after hypoglycemia-induced brain edema in rats. PLoS ONE. 2014;9(9):e107022. https:\/\/doi.org\/10.1371\/journal.pone.0107022.","journal-title":"PLoS ONE"},{"key":"843_CR51","doi-asserted-by":"publisher","unstructured":"Egleton RD, Campos CC, Huber JD, Brown RC, Davis TP. Differential effects of diabetes on rat choroid plexus ion transporter expression, (in eng). Diabetes. 2003;52(6):1496\u2013501. https:\/\/doi.org\/10.2337\/diabetes.52.6.1496.","DOI":"10.2337\/diabetes.52.6.1496"},{"issue":"2","key":"843_CR52","doi-asserted-by":"publisher","first-page":"e56264","DOI":"10.1371\/journal.pone.0056264","volume":"8","author":"R Prakash","year":"2013","unstructured":"Prakash R, Johnson M, Fagan SC, Ergul A. Cerebral neovascularization and remodeling patterns in two different models of type 2 diabetes. PLoS ONE. 2013;8(2):e56264. https:\/\/doi.org\/10.1371\/journal.pone.0056264.","journal-title":"PLoS ONE"},{"key":"843_CR53","doi-asserted-by":"publisher","unstructured":"Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570\u201381. https:\/\/doi.org\/10.1001\/jama.287.19.2570.","DOI":"10.1001\/jama.287.19.2570"},{"key":"843_CR54","doi-asserted-by":"publisher","unstructured":"Stehouwer CDA. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences. Diabetes. 2018;67(9):1729\u20131741. https:\/\/doi.org\/10.2337\/dbi17-0044.","DOI":"10.2337\/dbi17-0044"},{"key":"843_CR55","doi-asserted-by":"publisher","unstructured":"Mahroo A, Konstandin S, G\u00fcnther M. Blood-brain barrier permeability to water measured using multiple echo time arterial spin labeling MRI in the aging human brain, (in eng). J Magn Reson Imaging. 2024;59(4):1269\u201382. https:\/\/doi.org\/10.1002\/jmri.28874.","DOI":"10.1002\/jmri.28874"},{"key":"843_CR56","doi-asserted-by":"publisher","unstructured":"Shi W, et al. Imaging venous transit time and blood\u2013brain barrier permeability of the deep brain. Mag Res Med. 2026;96(2). https:\/\/doi.org\/10.1002\/mrm.70356.","DOI":"10.1002\/mrm.70356"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00843-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00843-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00843-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:47:38Z","timestamp":1787669258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00843-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00843-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9698981\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. It received approval by the Institutional Review Board (IRB) at UT Southwestern Medical Center (IRB approval number: STU-2023-0388). All participants provided written informed consent prior to participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Jaime P. Almandoz is a Consultant at AbbVie, Amgen, Boehringer Ingelheim, Eli Lilly, Haleon, Kailera, Metsera\/Pfizer, Novo Nordisk, Rivus, Rhythm Pharmaceuticals, and Wave Life Sciences. The other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}